Single User License: $4,900.00
Multi User License: $7,350.00
Enterprise License: $9,800.00
Drug-Eluting Stents Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Drug-Eluting Stents Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Drug-Eluting Stents market.
This research report categorizes the global Drug-Eluting Stents market by top players/brands, region, type and end user. This report also studies the global Drug-Eluting Stents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.
The global Drug-Eluting Stents market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Drug-Eluting Stents market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
Market size by Product
Rapamycin
Paclitaxel
Everolimus
Others
Market size by End User
Angina Pectoris
Myocardial Infarction
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Drug-Eluting Stents market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Drug-Eluting Stents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug-Eluting Stents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug-Eluting Stents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
1 Study Coverage
1.1 Drug-Eluting Stents Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drug-Eluting Stents Market Size Growth Rate by Product
1.4.2 Rapamycin
1.4.3 Paclitaxel
1.4.4 Everolimus
1.4.5 Others
1.5 Market by End User
1.5.1 Global Drug-Eluting Stents Market Size Growth Rate by End User
1.5.2 Angina Pectoris
1.5.3 Myocardial Infarction
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drug-Eluting Stents Market Size
2.1.1 Global Drug-Eluting Stents Revenue 2013-2025
2.1.2 Global Drug-Eluting Stents Sales 2013-2025
2.2 Drug-Eluting Stents Growth Rate by Regions
2.2.1 Global Drug-Eluting Stents Sales by Regions
2.2.2 Global Drug-Eluting Stents Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Drug-Eluting Stents Sales by Manufacturers
3.1.1 Drug-Eluting Stents Sales by Manufacturers
3.1.2 Drug-Eluting Stents Sales Market Share by Manufacturers
3.1.3 Global Drug-Eluting Stents Market Concentration Ratio (CR5 and HHI)
3.2 Drug-Eluting Stents Revenue by Manufacturers
3.2.1 Drug-Eluting Stents Revenue by Manufacturers (2013-2018)
3.2.2 Drug-Eluting Stents Revenue Share by Manufacturers (2013-2018)
3.3 Drug-Eluting Stents Price by Manufacturers
3.4 Drug-Eluting Stents Manuf ...
Main Categories